Radioactive Implant Shows Early Promise in Small Pancreatic Cancer Study

A Greek study, published in the international oncology journal Cancers, found that an Australian-developed radioactive implant (OncoSil device) stopped tumor growth in all assessed patients with unresectable locally advanced pancreatic cancer. Four of 17 patients, initially deemed inoperable, later underwent successful surgery. The device delivers beta radiation directly into the tumor, aiming for a higher dose to the cancer while sparing surrounding organs.